Abstract
Lupus erythematosus (LE) is an autoimmune, chronic inflammatory, often multisystem disease, seen in all populations worldwide. It is characterized by a wide spectrum of clinical symptoms and immune serological parameters, with variable evolution and prognosis. The skin is the most frequent site of involvement, showing variable erythematous lesions and overlapping features which make the diagnosis by the physician often difficult, particularly in pigmented or black skin. There are various classifications and different variants and subtypes of the disease with three major forms: The discoid or chronic cutaneous lupus (DLE), the subacute cutaneous lupus (SCLE), and the systemic form of the disease with involvement of the joints or visceral organs (SLE).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Findlay GH, Lups JG. The incidence and pathogenesis of chronic discoid lupus erythematosus. An analysis of 191 consecutive cases from the Transvaal. S Afr Med J. 1967;41:694–8.
Tebbe B, Orfanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus. 1997;6:96–104.
Ng PP, Tan SH, Koh ET. Epidemiology of cutaneous lupus erythematosus in a tertiary referral centre in Singapore. Australas J Dermatol. 2000;41:229–33.
Grönhagen CM, Nyberg F. Cutaneous lupus erythematosus: an update. Indian Dermatol Online J. 2014;5:7–13.
Callen JP. Chronic cutaneous lupus erythematosus: clinical, laboratory, therapeutic, and prognostic examination of 62 patients. Arch Dermatol. 1982;118:412–6.
Deligny C, Clyti E, Sainte Marie D, et al. Incidence of chronic cutaneous lupus erythematosus in French Guiana: a retrospective population-based study. Arthritis Care Res. 2010;62:279–82.
Johnson AE, Gordon C, Palmer RG, et al. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum. 1995;38:551–8.
Ogunbiyi AO, Daramola OO, Alese OO. Prevalence of skin diseases in Ibadan, Nigeria. Int J Dermatol. 2004;43:31–6.
Cherif F, Mebazaa A, Mokni M, et al. Childhood discoid lupus erythematosus: a Tunisian retrospective study of 16 cases. Pediatr Dermatol. 2003;20:295–8.
Mahfoudh A, Khaled A, Chtourou O, et al. Chronic lupus erythematosus: 104 Tunisian cases. Tunis Med. 2010;88:742–5.
Deligny C, Marie DS, Clyti E, et al. Pure cutaneous lupus erythematosus in a population of African descent in French Guiana: a restrospective population-based description. Lupus. 2012;21:1467–71.
Graham RR, Ortmann WA, Langefeld CD, et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet. 2002;71:543–53.
Fabbri P, Cardinall C, Giomi B, et al. Cutaneous lupus erythematosus. Orphanet Encyclopedia, October 2004.
Boeckler P, Cosnes A, Frances C, et al. Association of cigarette smoking but not alcohol consumption with cutaneous lupus erythematosus. Arch Dermatol. 2009;145:1012–6.
Wenzel J, Zahn S, Tüting T. Pathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets. Lupus. 2010;19:1020–8.
Jacyk WK, Damisah M. Discoid lupus erythematosus in the Nigerians. Br J Dermatol. 1979;100:131–5.
Verma SM, Okawa J, Propert KJ, et al. The impact of skin damage due to cutaneous lupus on quality of life. Br J Dermatol. 2014;170:315–21.
Jacyk WK, Bhana KN. Lupus erythematosus profundus in black South Africans. Int J Dermatol. 2006;45:717–21.
Nozile W, Adgerson CN, Cohen GF. Cutaneous lupus erythematosus in skin of color. J Drugs Dermatol. 2015;14:343–9.
Bertsias G, Cervera R, Boumpas D. Systemic lupus erythematosus: pathogenesis and clinical features. In: EULAR textbook on rheumatic diseases. Geneva, Switzerland: European League against Rheumatism; 2012. p. 476–505.
Lee HJ, Sinha AA. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies. Autoimmunity. 2006;39:433–44.
Word AP, Perese F, Tseng LC, et al. 25-OH vitamin D levels in African American and Caucasian/Hispanic cutaneous lupus subjects. Br J Dermatol. 2012;166:372–9.
Chang AY, Werth VP. Treatment of cutaneous lupus. Curr Rheumatol Rep. 2011;13:300–7.
Jewell ML, McCauliffe DP. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol. 2000;42:983–7.
Motswaledi MH, Khammissa RA, Wood NH, et al. Discoid lupus erythematosus as it relates to cutaneous squamous cell carcinoma and to photosensitivity. SADJ. 2011;66:340–3.
Molomo EM, Bouckaert M, Khammissa RA, et al. Discoid lupus erythematosus-related squamous cell carcinoma of the lip in an HIV-seropositive black male. J Can Res Ther. 2015;11:1036.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Buinsauskaité, E., Orfanos, C.E. (2018). Lupus Erythematosus in Pigmented and Black Skin. In: Orfanos, C., Zouboulis, C., Assaf, C. (eds) Pigmented Ethnic Skin and Imported Dermatoses. Springer, Cham. https://doi.org/10.1007/978-3-319-69422-1_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-69422-1_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-69421-4
Online ISBN: 978-3-319-69422-1
eBook Packages: MedicineMedicine (R0)